Tablet user information

Avemar Film-coated Tablets 

1.  What is the Avemar film-coated tablet?
The Avemar film-coated tablet is a dietary food for special medical purposes, for the supplementation of treatment of cancer patients.

 2. What is the active ingredient of Avemar?
The Avemar pulvis concentrate is a special, patented extract produced by pharmaceutical technology. Wheat germ is only the basic raw material of Avemar pulvis. Ten Avemar       film-coated tablets contain 7.4 g of Avemar pulvis concentrate. Ten Avemar film-coated tablets are equal to 1 packet (17 g) of conventional Avemar microgranulate. 

3. Does the Avemar film-coated tablet contain added sugar, sweetener or aroma?
No, it does not. 

4. In which cases is it recommended to take the Avemar film-coated tablet?
The Avemar film-coated tablet is suggested for the supplementation of the clinical oncological treatments (surgery, radiotherapy, chemotherapy, immunotherapy, etc.) of cancer patients. The Avemar film-coated tablet is recommended to be taken without interruption before, during the full course and after the completion of oncological treatments. Avemar film-coated tablet may be taken during any stage of a malignant disease. After surgery, the Avemar film-coated tablet  can be initiated when the patient is able to take oral food without complications for at least 4 days. 

5. When can the consumption of the Avemar film-coated tablet be initiated? 
It is recommended to start taking Avemar right after the recognition of a malignant disease (diagnoses). There is no need to wait for the start of the oncological treatments. 

6. What should be known before taking Avemar?
The product is not suitable for use as the sole source of nourishment. Avemar is not a replacement or a substitute for any oncological treatments or drugs!

7. How should the Avemar film-coated tablet be taken?
It is recommended to take Avemar continuously, without interruption. Following the completion of oncological treatments, it is also recommended to take the product for several years until the patient completely recovers. If the continuous taking of Avemar is interrupted or suspended for any reason, that can be restarted later again. 

8. When must not the product be taken?
The product is contraindicated during pregnancy and breastfeeding. Avemar is also strictly contraindicated for patients undergoing organ or tissue transplantation. 
This product must not be consumed by patients suffering from bleeding erosions and/or ulcers of the gastrointestinal tract (stomach and duodenal ulcers), enteritis/colitis (severe inflammations of the gastrointestinal tract) or Malabsorption Syndrome (serious impairment of absorption). The product is contraindicated in gluten sensitive enteropathies (celiac sprue) and for patients with hypersensitivity to any of the components of the product. 

9. In which cases should the application of the Avemar film-coated tablet be temporarily suspended?
It is advised to suspend the application of the Avemar at least two days before a planned gastroenteral diagnostic procedure, in which oral administration of contrast material (such as barium sulfate) to the intestinal tract will be used. The consumption of may be continued the day after the procedure. In every case, the instructions of the therapist should be respected. In the case of examinations or procedures should  be carried out on an empty stomach that must be taken into consideration relating to the consumption of Avemar also. 

 10. Can children take Avemar?
Avemar is not recommended for children younger than 14 years of age.  

11. What unwanted effects may Avemar have?
Avemar may very infrequently have side effects, such as soft stool, unsettled stomach and nausea. 

12. Can Avemar be taken together with other drugs, preparations?
Yes, it can. The Avemar should only be taken either 2 hours before or after the consumption of vitamin-C or any product containing vitamin C. It is highly recommended to take the Avemar film-coated tablet at a different time from other supplements or drugs. 

13. What is the recommended daily dose and when should it be taken? 
Body weight less than 50 kg: 4 film-coated tablets twice daily
Body weight of 50-90 kg: 5 film-coated tablets twice daily
Body weight above 90 kg: 7 film-coated tablets twice daily
It is recommended to take the half of the daily dosage in the morning and the other half of that in the evening.

14. How should Avemar film-coated tablet be stored and transported?
The product should be stored protecting from heat, at  room temperature (max 22oC). If the temperature is above 22oC, then the product should be stored in refrigerator. Keep out of reach of children! Special caution should be taken to protect the product from any long-lasting extreme heat effect during its transportation. 

15. Are the Avemar film-coated tablet and the well-known Avemar microgarnulate in packets produced by the same manufacturer?
Yes, both products are manufactured by Biropharma Ltd. In case of both products, the active ingredient, Avemar pulvis, is made by the same technology using the same ingredients. 

16. What kind of scientific studies have been carried out with Avemar?
Please, visit the website, where you will find a summary of all the prestigious Hungarian and international publications that cover the results and experiences of the clinical studies carried out with Avemar.

Packaging units:  2 bottles eacsh of 150 tablets
Net weight: 312 g (300 film-coated tablets each of 1040mg)
Notification number: 1125/2010 OÉTI

If you have any question, request or comment, please contact us

By Phone

+36 70 466 65 03
Monday-Thursday: 10-18 pm, Friday: 10-17 pm

By Mail

H-1066 Budapest, Ó utca 4., Hungary

By E-mail

Follow us on Facebook

Follow us on Twitter


This site is intended for the citizens of the European Union only. The information on this website is provided for informational purposes only and is not meant to diagnose or treat any health problem or disease or be a substitute for advice provided by a doctor or other qualified health care professional. Patients should always consult with a doctor or other health care professionals for medical advice or information about a diagnosis and/or treatment. In the case of diagnosis or treatment of any disease, particularly tumour related diseases, a health care professional should always be consulted. Do not attempt to self-treat.

Privacy Policy